GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensei Biotherapeutics Inc (HAM:407) » Definitions » Price-to-Operating-Cash-Flow

Sensei Biotherapeutics (HAM:407) Price-to-Operating-Cash-Flow : (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sensei Biotherapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-23), Sensei Biotherapeutics's share price is €0.554. Sensei Biotherapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.96. Hence, Sensei Biotherapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Sensei Biotherapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

HAM:407's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.48
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Sensei Biotherapeutics's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.28. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.96.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -24.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 25.90% per year.

During the past 6 years, Sensei Biotherapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 58.30% per year. The lowest was -24.10% per year. And the median was -22.20% per year.


Sensei Biotherapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sensei Biotherapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensei Biotherapeutics Price-to-Operating-Cash-Flow Chart

Sensei Biotherapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - - - -

Sensei Biotherapeutics Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sensei Biotherapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Sensei Biotherapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sensei Biotherapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sensei Biotherapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sensei Biotherapeutics's Price-to-Operating-Cash-Flow falls into.



Sensei Biotherapeutics Price-to-Operating-Cash-Flow Calculation

Sensei Biotherapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.554/-0.963
=

Sensei Biotherapeutics's Share Price of today is €0.554.
Sensei Biotherapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.96.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Sensei Biotherapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sensei Biotherapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Sensei Biotherapeutics (HAM:407) Business Description

Traded in Other Exchanges
Address
1405 Research Boulevard, Suite 710, Boston, MA, USA, 02210
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. The company currently has three investigational products. 1) SNS-101 is a conditionally active monoclonal antibody targeting the immune checkpoint VISTA (V-domain Ig suppressor of T-cell activation): 2) SNS-102 is a conditionally active monoclonal antibody targeting VSIG4 (V-Set and Immunoglobulin Domain Containing 4), an immune checkpoint often expressed on macrophages: 3) SNS-103 is a conditionally active monoclonal antibody targeting ENTPDase1 (ecto-nucleoside triphosphate diphosphohydrolase-1), also known as CD39.

Sensei Biotherapeutics (HAM:407) Headlines

No Headlines